Nobelists Beat Adversity To Advance Science

The recipients of the 1997 Nobel Prizes in science, who will receive their awards on December 10, have traveled the vigorous intellectual journey of science.

Written byPaul Smaglik
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

The recipients of the 1997 Nobel Prizes in science, who will receive their awards on December 10, have traveled the vigorous intellectual journey of science. They all toppled old theories while building new ones. Along the way, they gained collaborations and corroboration from colleagues. They also endured skepticism, which in some cases still persists, despite their noted accomplishments.

Work conducted by Prusiner and many others has resulted in enough evidence to convince the Nobel Prize committee and much of the scientific community that prions play a role in causing neurodegenerative diseases including kuru, Creutzfeldt-Jakob disease, and transmissible spongiform encephalopathies such as scrapie and mad cow disease. Most scientists now accept Prusiner's hypothesis that prions-tiny proteins found in nerve cells, white blood cells, and the brain surface-sometimes mysteriously fold. These misshapen proteins somehow trigger neighbor proteins to behave similarly. The resulting chain reaction of destruction degenerates the brain.

Prusiner; William J. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies